REVEAL PHARMACEUTICALS
Gadolinium-free MRI contrast agents for all patients who need crucial medical imaging.
REVEAL PHARMACEUTICALS
Industry:
Health Diagnostics Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.revealpharma.com
Total Employee:
1+
Status:
Active
Total Funding:
4.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag Nginx
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Employees Featured
Peter Caravan Co-Founder @ Reveal Pharmaceuticals
Co-Founder
Vera Hoffman CEO & Co-Founder @ Reveal Pharmaceuticals
CEO & Co-Founder
2016-01-01
Founder
Investors List
National Cancer Institute
National Cancer Institute investment in Grant - Reveal Pharmaceuticals
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Reveal Pharmaceuticals
Massachusetts Life Sciences Center
Massachusetts Life Sciences Center investment in Grant - Reveal Pharmaceuticals
National Cancer Institute
National Cancer Institute investment in Grant - Reveal Pharmaceuticals
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Reveal Pharmaceuticals
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Reveal Pharmaceuticals
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Reveal Pharmaceuticals
MassChallenge
MassChallenge investment in Grant - Reveal Pharmaceuticals
More informations about "Reveal Pharmaceuticals"
Reveal Pharmaceuticals | Home
Reveal's pipeline: ground-breaking fibrogenesis imaging agents. Building on research by Reveal's co-founder, Professor Peter Caravan (Harvard Medical School & Massachusetts General …See details»
Reveal Pharmaceuticals - Crunchbase Company Profile & Funding
Reveal Pharmaceuticals is the gadolinium free MRI contrast agent. View contacts for Reveal Pharmaceuticals to access new leads and connect with decision-makers. Gadolinium-free MRI …See details»
Reveal Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Reveal Pharmaceuticals, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Reveal Pharmaceuticals - LinkedIn
Biotechnology Innovation Organization MassBio. Reveal Pharmaceuticals | 481 followers on LinkedIn. The gadolinium-free MRI contrast agent - The future of medical insight | Reveal is...See details»
Reveal Pharma - BIO International Convention 2024
Jun 3, 2024 · Reveal is transforming medical insight with the first gadolinium-free general purpose MRI contrast agent RVP-001 (Phase 2 clinical studies) and fibrogenesis-targeted imaging agents (pre-clinical).See details»
Reveal Pharmaceuticals | Insight
Mn-PyC3A is more completely eliminated than Gd-DOTA from 5/6 nephrectomy rats after 7 days. Dynamic and delayed phase PET/MR results confirm rapid renal and hepatobiliary clearance of Mn-PyC3A in both normal and 5/6 …See details»
Reveal Pharma - BIO International Convention | BIO
Jun 5, 2023 · Reveal is a clinical stage company positioned to transform medical insight. Our first in class imaging drugs address two major needs: Gadolinium accumulates in the brain and body of every person using current MRI contrast …See details»
Reveal Pharmaceuticals - MassBio
RVP technology provides a platform for precision imaging of fibrosis, thrombosis, lymph nodes, and more: these agents will inform the use of targeted therapeutics and guide personalized …See details»
Reveal Pharmaceuticals | Reveal Wins $3M in SBIR grants from …
Cambridge MA, 28 September 2021 - Reveal Pharmaceuticals, an innovative company developing the first general purpose gadolinium-free MRI contrast agent, is pleased to …See details»
Reveal Pharmaceuticals - Overview, News & Similar companies
View Reveal Pharmaceuticals (www.revealpharma.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Reveal Pharmaceuticals - Products, Competitors, Financials, …
Reveal Pharmaceuticals is a company focused on the development of innovative medical imaging agents within the healthcare sector. Their main offerings include gadolinium-free MRI contrast …See details»
Reveal Pharmaceuticals, Inc. - VentureRadar
Website: http://www.revealpharma.com Develops gadolinium-free contrast agents for MRI and innovative imaging agents, enhancing diagnostic accuracy while prioritizing patient safety and …See details»
Reveal Pharmaceuticals - PitchBook
Developer of MRI contrast agent designed to provide a gadolinium-free direct replacement for all current GBCAs (Gadolinium-Based Contrast Agent).See details»
Reveal Pharma | Cambridge, MA, USA Startup - gust.com
Reveal is the future of medical imaging: + safer gadolinium-free contrast-enhanced MRI scans + precision imaging platform: empowering personalized medicine. Starting a startup? Join the …See details»
Reveal Pharmaceuticals - Company Profile - Tracxn
Oct 11, 2024 · Reveal Pharmaceuticals provides gadolinium-free MRI contrast agent. The company has developed manganese-based contrast agent, Mn-PyC3A. Their agent reduces …See details»
Reveal Pharmaceuticals | Reveal Recruits Leading Physician from …
Cambridge MA, 30 September 2021 - Reveal Pharmaceuticals, an innovative company developing the first general purpose gadolinium-free MRI contrast agent, is delighted to …See details»
Reveal Pharmaceuticals - Craft
Reveal Pharmaceuticals is a biotech company specializing in medical imaging. It offers gadolinium-free MRI (magnetic resonance imaging) contrast agents. Reveal Pharmaceuticals …See details»
Reveal Expanded Access Policy - revealpharma.com
Expanded access, sometimes called compassionate use, refers to the use of an investigational new drug outside of a clinical trial for patients with serious or life-threatening conditions who …See details»
NEWS RELEASE November 2020 - revealpharma.com
Reveal Pharmaceuticals, Inc. was founded in 2016 by CEO Vera Hoffman and Massachusetts General Hospital / Harvard Medical School researchers Eric Gale and Peter Caravan with the …See details»
GADOLINIUM-FREE MRI CONTRAST AGENT EXCELS VS GBCAS
To improve safety, Mn-PyC3A is based on the biocompatible element manganese, which is essential for human life. The study, published in this month’s Investigative Radiology, directly …See details»